Scilex Holding Co (SCLX)
NASDAQHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
$5.42+2.65%
Close 2026-09-04 · 1-day change
NASDAQHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
QuarterlyIQ Insights · SCLX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance recently climbed back into the top half of its industry — confirming the recovery.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -74.4% |
| Our one-year growth estimate | diamond | -19.8% |
Growth built into the price is above our model estimate.
The price assumes 54.6 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Elevated risk of a next-quarter earnings miss: this name has been missing across recent quarters and is on a run of consecutive earnings misses. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 11 industry peers · Company calendar date is not available
SCLX — credit agreement
Dated 2026-08-12
Entry into a Material Definitive Agreement. On August 8, 2026 (the “Effective Date”), Scilex Holding Company (the “Company”) entered into a Promissory Note (Revolving Line of Credit) (the “Note”) with Vivasor, Inc. (“Vivasor”), as borrower, pursuant to which the Company established in favor of Vivasor an uncommitted revolving line of credit in a maximum aggregate principal amount of up to $20,000,000 (the “Maximum Credit Amount”). The Note has a stated maturity of 120 months from the Effectiv…
Why it matters: This acquisition could enhance Scilex's product portfolio and market position. It is a key part of their growth strategy.
Supportive ifThe acquisition closes successfully by the end of Q2 2026. Shares will be listed on Nasdaq.
Worry ifThe acquisition does not close. This is due to regulatory or approval issues.
Why it matters: New forms of dividends could attract different investors.
Watch forAnnouncement of a new form of dividend that is well-received by the market.
Also watch forNo new dividends have been announced. They are focusing on managing cash.
Why it matters: This investment could provide crucial funding for Scilex's growth and M&A activities.
Supportive ifThe investment closes. Scilex receives the funds.
Worry ifThe investment does not close. This is due to unmet conditions or regulatory issues.
Why it matters: This special dividend could attract interest from investors. It shows Scilex's smart use of capital.
Watch forThe dividend is given to shareholders on or after May 26, 2026.
Also watch forThe dividend distribution is delayed or canceled. This is due to unmet conditions.
Why it matters: This special dividend plan may attract investors and change how stockholders feel.
Watch forMany shareholders choose to get the Dream Bowl Tokens. This shows strong interest.
Also watch forFew shareholders are choosing to get the Dream Bowl Tokens.
Why it matters: New dividends might attract investors. They can also show the company's financial strength.
Supportive ifThe board announced a new type of dividend.
Worry ifNo news or bad comments on dividend plans.
Why it matters: Progress on buybacks may show management's trust in the company's value and future.
Supportive ifThe company reports the shares it bought back under the buyback program.
Worry ifNo shares are reported as bought back after the announcement.
Why it matters: New M&A deals could boost growth and investor confidence. This is a key priority for management.
Supportive ifAnnouncement of a new M&A deal that aligns with management's growth strategy.
Worry ifNo new M&A announcements or delays in planned transactions.
Why it matters: A new M&A deal could signal growth and improve investor confidence.
Supportive ifA completed acquisition could add value to the company.
Worry ifNo new M&A announcements. The focus remains on current operations.
Why it matters: This investment is key for Scilex's growth plans and future acquisitions. It shows confidence in Scilex's strategy.
Supportive ifThe investment is complete. All approvals from regulators and shareholders are in place.
Worry ifThe investment does not close. This is due to unmet conditions or regulatory issues.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$300 on $10,000 · ±3.0% | How much price usually moves either way. |
| Bad day | $1,076 loss on $10,000 · 10.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,027 loss on $10,000 · 80.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.